Biofilm Assay Calculators

0 calculators tagged with “Biofilm Assay”

A biofilm assay quantifies the formation of structured microbial communities attached to a surface (biofilm) and can assess the effectiveness of antimicrobial agents against these biofilms. The most common method is the crystal violet (CV) biofilm assay in 96-well microtiter plates — bacteria form biofilms on the well surfaces; unattached cells are washed away; biofilm is stained with crystal violet; the dye is solubilized and OD₅₉₀ measured as a proxy for biofilm biomass. Biofilms are clinically significant because they are 10–1,000× more resistant to antibiotics than planktonic bacteria.

All Calculators

No calculators found for this topic.

Crystal Violet Biofilm Assay Protocol

  1. Inoculate bacteria into 96-well plate wells at standardized concentration (typically 10⁵–10⁷ CFU/mL in growth medium)
  2. Incubate at 37°C for 24–48 hours (static or shaking depending on protocol)
  3. Remove medium by aspiration or plate inversion; wash 2–3× with PBS to remove non-adherent planktonic cells
  4. Fix biofilm by air-drying or methanol treatment (optional)
  5. Stain with 0.1–1% crystal violet solution for 15–20 minutes
  6. Remove excess dye; wash with water; air-dry
  7. Solubilize dye with 95% ethanol or glacial acetic acid (33%)
  8. Measure OD₅₉₀ (or OD₅₅₀) — proportional to biofilm biomass

Minimum Biofilm Eradication Concentration (MBEC)

The minimum drug concentration that eliminates ≥ 99.9% of biofilm bacteria. MBEC is typically 100–1,000× higher than MIC (planktonic). MBEC is determined by treating established biofilms with antibiotic concentrations, washing, sonicating to release bacteria, and plating for viability. The MBEC assay plate (Innovotech) allows high-throughput MBEC testing.

Biofilm Formation Stages

Attachment → Microcolony formation → Biofilm maturation (extracellular polysaccharide, eDNA matrix) → Dispersal. Quorum sensing controls maturation and dispersal.

Glossary

Biofilm
A structured microbial community in a self-produced EPS matrix attached to a surface; 10–1,000× more antibiotic-resistant than planktonic cells; clinically significant in device infections and chronic wounds.
Crystal Violet (CV) Assay
A biofilm quantification method staining adherent biofilm with crystal violet; OD₅₉₀ after dye solubilization proportional to biofilm biomass; standard high-throughput method in 96-well plates.
MBEC
Minimum Biofilm Eradication Concentration; lowest antibiotic concentration killing ≥99.9% of biofilm bacteria; typically 100–1,000× higher than MIC due to biofilm tolerance mechanisms.

Frequently Asked Questions

A biofilm is a structured community of microorganisms encased in a self-produced matrix of extracellular polymeric substances (EPS) — polysaccharides, proteins, eDNA, and lipids — attached to a biotic or abiotic surface. Clinical significance: Antibiotic resistance: bacteria in biofilms are 10–1,000× more resistant to antibiotics than their planktonic counterparts due to: reduced penetration of antibiotics through the EPS matrix; slow-growing 'persister' cells in the biofilm interior; altered gene expression in biofilm state. Medical device infections: biofilms form on catheters, prosthetic joints, heart valves, contact lenses; these infections are extremely difficult to treat and often require device removal. Chronic infections: Pseudomonas aeruginosa biofilms in CF lung; Staphylococcus epidermidis on implants; Staphylococcus aureus in chronic wounds.

Crystal violet (CV) binds to negatively charged biofilm components (bacterial cells and extracellular polysaccharides). The assay quantifies total biofilm biomass: Bacteria adhere to well surface during incubation → form biofilm. Washing removes planktonic cells → only adherent biofilm remains. CV staining: the dye penetrates and binds to all biofilm material (not just live cells). Solubilization and OD₅₉₀ reading: absorbance is proportional to dye amount, which is proportional to biofilm biomass. Controls: sterile medium (negative control); wells with known biofilm-forming reference strain (positive control). Quantification: report OD₅₉₀ of treated vs. untreated biofilm; calculate % inhibition. Limitation: CV measures total biomass (live + dead), not viability — combine with viable count (sonication + plating) for complete characterization.

MIC (Minimum Inhibitory Concentration): lowest antibiotic concentration inhibiting visible growth of planktonic (free-floating) bacteria. Measured in broth microdilution in 16–20 hours. MBEC (Minimum Biofilm Eradication Concentration): lowest antibiotic concentration killing ≥ 99.9% of bacteria in an established biofilm. MBEC is typically 100–1,000× higher than MIC because biofilm bacteria are far more tolerant of antibiotics (EPS barrier, slow growth, persister cells). Clinical significance: treating a catheter-associated infection with an antibiotic at MIC concentrations will fail to eradicate the biofilm. MBEC provides a more relevant therapeutic target. Measurement: establish biofilm → treat with antibiotic concentrations → wash → sonicate (detach bacteria) → plate for CFU → MBEC = lowest concentration achieving ≥ 3-log kill.

Factors promoting biofilm formation: Surface properties: rough, hydrophobic surfaces favor initial attachment. Nutrient availability: adequate but limited nutrients support stable biofilm (very high or very low nutrients can inhibit). Quorum sensing: bacteria communicate via chemical signals (AHL, AI-2) to coordinate biofilm maturation and dispersion. Flow conditions: moderate shear stress can actually promote biofilm (mechanically stimulates attachment). Temperature and pH: each species has optimal biofilm conditions. Factors inhibiting biofilm: Antibiofilm agents: silver ions; quaternary ammonium compounds; cationic peptides; quorum sensing inhibitors (furanones, garlic extracts). Surface coatings: hydrophilic or zwitterionic polymer coatings; silver-impregnated catheters. Mechanical disruption: sonication, turbulent flow, brush scrubbing. Biofilm dispersal signals: nitric oxide (NO); fatty acids; regulatory proteins that trigger dispersal phase.